Dr. Charis Durham, MD

Dr. Durham practices at Brazos Valley Cancer Center in Bryan, Texas.

Dr. Durham's NPI, 1538547401, was assigned on May 12, 2015. Dr. Durham graduated from Texas A&M College of Medicine - Bryan in 2015. Dr. Durham holds Texas license R6000.

Dr. Durham's primary practice is Brazos Valley Cancer Center, at 2215 E Villa Maria Rd, Bryan, TX 77802 in Brazos County. The practice phone is (979) 776-2000.

Dr. Durham's primary practice is Brazos Valley Cancer Center in Bryan, Texas. Dr. Durham is also affiliated with St. Joseph Health Regional Hospital. The medical group on file is Brazos Valley Cancer Center. Dmand AI also links Dr. Durham to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Durham practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Durham's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Durham is board certified in hematology by the American Board of Internal Medicine. Dr. Durham is licensed in Texas.

Dmand AI lists chronic anemia, chronic kidney disease, deep vein thrombosis (DVT), osteoporosis, purpura and thrombocytopenia, tobacco use and varicose veins among the conditions Dr. Durham treats.

CMS data shows 101,609 Medicare services from Dr. Durham across 41 procedure codes in 2024, for 555 Medicare patients. Medicare paid $1,151,971 for them. Every service was in an office.

CMS counts 555 Medicare patients who saw Dr. Durham in 2024. The largest group is 65 to 74, with 241 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Durham's median patient age at 71, with 60% women.

In 2024, Dr. Durham wrote 1,241 Medicare Part D claims for 192 patients. 80% of them were for generic drugs. CMS names the drug for 969 of them, across 40 drugs with 11 or more claims each, at $2,782,806 in total drug cost. In 2023, CMS named 451 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Durham for performance year 2024, reported as part of a group. Dr. Durham accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Durham, published from 2017 to 2022. 2022 was the busiest year, with 2. Dr. Durham has published most often in Proc (Bayl Univ Med Cent). Dr. Durham's most frequent co-authors are Roma Bhandarkar, MD, Micah Matthew Burch, MD and Jerry D. Fan, MD.

CMS Open Payments shows 235 general payments to Dr. Durham from 65 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 88% of the total. Janssen Pharmaceuticals, Inc paid the most, $646.

Dr. Durham graduated from Texas A&M College of Medicine - Bryan in 2015.

Dr. Durham is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.